940
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Management of Juvenile idiopathic arthritis-associated uveitis duringthe COVID-19 pandemic in a pediatric referral center in Lombardy

, MD, , MD, FEBO, , MD & , MD
Pages 1305-1307 | Received 30 May 2020, Accepted 21 Jul 2020, Published online: 25 Sep 2020

References

  • Istituto Superiore di Sanità. Aggiornamento nazionale 20 maggio 2020-0re 16:00. Istituto Superiore di Sanità; 2020.
  • Signorelli C, Scognamiglio T, Odone A. COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population. Acta Biomed. 2020;91:175–179.
  • Lu X, Xiang Y, Du H, Wong GW-K. SARS-CoV-2 infection in children – understanding the immune responses and controlling the pandemic. Pediatr Allergy Immunol. doi:10.1111/pai.13267.
  • Cron RQ, Chatham WW. The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic. J Rheumatol. 2020. doi:10.3899/jrheum.200492.
  • Xia J, Tong J, Liu M, Shen Y, Guo D Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020. doi:10.1002/jmv.25725.
  • Reviglio VE, Osaba M, Reviglio V, Chiaradia P, Kuo IC, O’Brien TP. COVID-19 and Ophthalmology: A New Chapter in an Old Story. Med Hypothesis Discov Innov Ophthalmol 2020;9:71–73.
  • Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020;258:1049–1055.
  • Borrelli E, Sacconi R, Querques L, et al. Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy. Eye. 2020;34(7):1175, 1176. doi:10.1038/s41433-020-0880-6.
  • Linee Guida e Raccomandazioni SOI. Emergenza sanitaria da SARS-CoV-2. Riorganizzazione dell’attività assistenziale oculistica nella fase 2. Approvate dalla Società Oftalmologica Italiana −3 maggio 2020. Primo aggiornamento −10 maggio 2020.
  • Favalli EG, Ingegnoli F, Cimaz R, Caporali R. What is the true incidence of COVID-19 in patients with rheumatic diseases? Annals of the Rheumatic Diseases. 2020;annrheumdis-2020-217615. doi:10.1136/annrheumdis-2020-217615.
  • Costi S, Caporali R, Cimaz R. Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy. Pediatr Drugs. 2020;22(3):263–264. doi:10.1007/s40272-020-00395-2.
  • Filocamo G, Minoia F, Carbogno S, Costi S, Romano M, Cimaz R. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs. J Rheumatol. 2020;jrheum.200483. doi:10.3899/jrheum.200483.
  • Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol. 2020;18(1):35. doi:10.1186/s12969-020-00422-z.
  • PReS – English: News Story. https://www.pres.eu/news/newsstory.html?id=29.
  • Li J-PO, Lam DSC, Chen Y, Ting DSW, Li J-PO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus disease 2019 (COVID-19): the importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020;104(3):297–298. doi:10.1136/bjophthalmol-2020-315994.
  • Sadhu S, Agrawal R, Pyare R, et al. COVID-19: limiting the Risks for Eye Care Professionals. Ophthalmol Ther. 2020;9(2):231–234. doi:10.1007/s40123-020-00251-z.
  • Parravano M, Borrelli E, Costanzo E, Sacconi R, Varano M, Querques G. Protect Healthcare Workers and Patients from COVID-19: the Experience of Two Tertiary Ophthalmology Care Referral Centers in Italy. Ophthalmol Ther. 2020;9:231–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.